Question 1

What is Xenon Pharmaceuticals's total operating expenses?

Accepted Answer

Xenon Pharmaceuticals (XENE) reported total operating expenses of $123.16M in Q2 2026.

Question 2

How has Xenon Pharmaceuticals's total operating expenses changed year-over-year?

Accepted Answer

Xenon Pharmaceuticals's total operating expenses increased by 30.7% year-over-year, from $94.23M to $123.16M.

Question 3

What is the long-term trend for Xenon Pharmaceuticals's total operating expenses?

Accepted Answer

Over 4 years (2021 to 2025), Xenon Pharmaceuticals's total operating expenses has grown at a 40.6% compound annual growth rate (CAGR), from $97.43M to $380.57M.

Question 4

What does total operating expenses mean?

Accepted Answer

The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Line item	Three Months Ended June 30, 2026	Three Months Ended June 30, 2025	Six Months Ended June 30, 2026	Six Months Ended June 30, 2025
Operating expenses:
Research and development	99,224	74,985	187,732	136,185
General and administrative	23,931	19,244	47,751	38,282
Total operating expenses	123,155	94,229	235,483	174,467
Loss from operations	(123,155)	(94,229)	(235,483)	(166,967)
Other income:
Interest income	12,145	7,199	19,052	15,282
Foreign exchange gain (loss)	(311)	1,698	237	1,733

Total Operating Expenses at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Xenon Pharmaceuticals's total operating expenses.

Xenon Pharmaceuticals XENE Total Operating Expenses